Beaumont Financial Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-40,680
Closed -$1.79M 314
2020
Q2
$1.79M Buy
40,680
+21,594
+113% +$923K 0.19% 94
2020
Q1
$717K Sell
19,086
-2,322
-11% -$97.8K 0.09% 119
2019
Q4
$943K Sell
21,408
-16,398
-43% -$689K 0.09% 137
2019
Q3
$1.56M Buy
+37,806
New +$1.55M 0.16% 101
2019
Q2
Sell
-44,310
Closed -$1.71M 250
2019
Q1
$1.71M Sell
44,310
-58,770
-57% -$2.13M 0.18% 88
2018
Q4
$3.43M Buy
103,080
+858
+0.8% +$29.7K 0.56% 44
2018
Q3
$3.88M Buy
102,222
+7,536
+8% +$268K 0.39% 59
2018
Q2
$3.17M Buy
94,686
+44,244
+88% +$1.44M 0.34% 62
2018
Q1
$1.55M Sell
50,442
-54,390
-52% -$1.68M 0.17% 83
2017
Q4
$3.03M Sell
104,832
-2,208
-2% -$63.7K 0.36% 65
2017
Q3
$2.98M Buy
107,040
+402
+0.4% +$11.1K 0.37% 64
2017
Q2
$2.96M Buy
106,638
+49,776
+88% +$1.32M 0.38% 64
2017
Q1
$1.44M Buy
+56,862
New +$1.38M 0.2% 88

Other funds holding IHI

Beaumont Financial Advisors's IHI Position: Q3 2020 in Review

Beaumont Financial Advisors sold out of iShares US Medical Devices ETF (IHI) in Q3 2020, closing a stake of 40,680 shares — an estimated $1.79M sold.

Beaumont Financial Advisors first reported a position in IHI in Q1 2017 and held it in 13 quarters. The position peaked at $3.88M in Q3 2018. 488 funds tracked by Wall St. Rank hold IHI as of Q3 2020.

  • Beaumont Financial Advisors reported no remaining iShares US Medical Devices ETF position as of Q3 2020 after selling out during the quarter.
  • Beaumont Financial Advisors sold 40,680 iShares US Medical Devices ETF shares in Q3 2020, an estimated $1.79M.
  • Beaumont Financial Advisors first reported a position in iShares US Medical Devices ETF in Q1 2017 and held it in 13 quarters.
  • Beaumont Financial Advisors's iShares US Medical Devices ETF position peaked at $3.88M in Q3 2018.
  • 488 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2020.

Based on Beaumont Financial Advisors's 13F filing for Q3 2020, filed 2 Nov 2020.